Why the Challenger share price jumped 13% today

The Challenger Ltd (ASX:CGF) share price jumped around 13% after reporting its result for the six months to 31 December 2019.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Annuity provider Challenger Ltd (ASX: CGF) reported its half-year result to 31 December 2019 today, causing the share price to jump 13%.

Challenger has been through a rough time over the past year with Australia's falling interest rate and the financial services royal commission which caused disruption to the financial advice sector.

Challenger's pleasing numbers

Challenger reported that group assets under management (AUM) rose 10% to $86 billion.

Normalised net profit before tax was up 3% to $279 million, though normalised net profit after tax (NPAT) dropped 4% to $191 million.

What does "normalised" net profit mean? It's Challenger's profit measure which it thinks better reflects the underlying operating performance of the business. The normalised profit figures exclude investment experience and significant items. The 'investment experience' compares the actual investment returns against Challenger's long-term assumptions for investment returns as well as any impact of changes in economic variables and assumptions used to value liabilities.

Looking at some of the other numbers, Challenger's statutory profit rose by $214 million to $220 million and it achieved a normalised return on equity (ROE) of 15.2% which was 0.30% above target.

Total life sales were up 15% to $3.1 billion thanks to Challenger's Japanese partnership and Australian institutional sales, offset by lower domestic sales because of industry disruption.

Total annuity sales were down 9% ($0.2 billion) to $2 billion. Other Life sales were up 97% to $1.2 billion which showed strong demand from institutional clients who want guaranteed returns in this low interest rate environment.

Challenger had excess regulatory capital and group cash of $1.5 billion, up $0.1 billion.

Challenger dividend

The Challenger board decided to maintain the interim dividend at 17.5 cents per share.

Challenger's current focus

Challenger is focusing on supporting more direct engagement with prospective customers, increasing support to advisers to better meet changing customer needs and expanding its capabilities to partner with institutional clients.

Challenger outlook

Challenger is expecting that its FY20 normalised net profit before tax is expected to be around the top end of Challenger's guidance range of $500 million to $550 million. It's also on track to achieve its normalised ROE target of the RBA cash rate plus a margin of 14%.

The full year dividend is expected to remain unchanged from FY19 with a full year payment of 35.5 cents per share, which is above the target dividend payout ratio of 45% to 50% of normalised profit after tax, reflecting Challenger's strong capital position and confidence in future growth.

Foolish takeaway

Given the operating environment, this was a solid result by Challenger and it has restored a lot of sentiment about the medium-term outlook. It has an attractive long-term future, though I am still a bit wary about changing interest rates.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Challenger Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 34% on strong earnings growth

Investors just sent this ASX All Ords stock surging 34%. Here’s what’s happening.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Dimerix, Newmont, Regal Partners, and Titomic shares are storming higher

These shares are having a good finish to the week. Let's see why.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Gainers

Why Fortescue, Lynas, PEXA, and Regis Healthcare shares are charging higher

These shares are having a strong session on Thursday. But why?

Read more »

A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
Share Gainers

Why Capricorn Metals, Insignia, Perseus Mining, and Qoria shares are storming higher

These shares are having a strong session on Tuesday. But why?

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Amaero, AMP, Block, and South32 shares are racing higher today

These shares are starting the week on a positive note. But why?

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another momentous session for ASX shares this Friday.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Gainers

Why BHP, Catalyst Metals, Mesoblast, and Pilbara Minerals shares are shooting higher

These shares are ending the week with a bang. But why?

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

The Mesoblast share price just rocketed 38%! Here's why

ASX investors just sent the Mesoblast share price up 38%. But why?

Read more »